Annual Total Long Term Liabilities
$1.40 M
-$1.07 M-43.34%
December 1, 2023
Summary
- As of February 6, 2025, CSCI annual total long term liabilities is $1.40 million, with the most recent change of -$1.07 million (-43.34%) on December 1, 2023.
- During the last 3 years, CSCI annual total long term liabilities has fallen by -$1.37 million (-49.46%).
- CSCI annual total long term liabilities is now -62.49% below its all-time high of $3.72 million, reached on December 1, 1996.
Performance
CSCI Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$15.59 M
+$1.67 M+11.98%
September 1, 2024
Summary
- As of February 6, 2025, CSCI quarterly total long term liabilities is $15.59 million, with the most recent change of +$1.67 million (+11.98%) on September 1, 2024.
- Over the past year, CSCI quarterly long term liabilities has increased by +$14.19 million (+1016.38%).
- CSCI quarterly long term liabilities is now at all-time high.
Performance
CSCI Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
CSCI Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -43.3% | +1016.4% |
| 3 y3 years | -49.5% | +1016.4% |
| 5 y5 years | +153.6% | +1016.4% |
CSCI Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -43.3% | at low | at high | +1103.5% |
| 5 y | 5-year | -49.5% | at low | at high | +1103.5% |
| alltime | all time | -62.5% | +2123.4% | at high | >+9999.0% |
COSCIENS Biopharma Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.59 M(+12.0%) |
| Jun 2024 | - | $13.92 M(+974.7%) |
| Mar 2024 | - | $1.30 M(-7.2%) |
| Dec 2023 | $1.40 M(-43.3%) | $1.40 M(-19.0%) |
| Sep 2023 | - | $1.72 M(-16.2%) |
| Jun 2023 | - | $2.06 M(-11.4%) |
| Mar 2023 | - | $2.32 M(-5.7%) |
| Dec 2022 | $2.46 M(+33.2%) | $2.46 M(+9.5%) |
| Sep 2022 | - | $2.25 M(+0.2%) |
| Jun 2022 | - | $2.25 M(+13.9%) |
| Mar 2022 | - | $1.97 M(+6.6%) |
| Dec 2021 | $1.85 M(-33.0%) | $1.85 M(-28.6%) |
| Sep 2021 | - | $2.59 M(-4.9%) |
| Jun 2021 | - | $2.73 M(-0.3%) |
| Mar 2021 | - | $2.73 M(-1.0%) |
| Dec 2020 | $2.76 M(+12.2%) | $2.76 M(+22.6%) |
| Sep 2020 | - | $2.25 M(-0.2%) |
| Jun 2020 | - | $2.26 M(+1.7%) |
| Mar 2020 | - | $2.22 M(-9.8%) |
| Dec 2019 | $2.46 M(+347.2%) | $2.46 M(-6.8%) |
| Sep 2019 | - | $2.64 M(-3.0%) |
| Jun 2019 | - | $2.72 M(-1.3%) |
| Mar 2019 | - | $2.76 M(+401.2%) |
| Dec 2018 | $550.50 K(-42.2%) | $550.50 K(-8.5%) |
| Sep 2018 | - | $601.70 K(-9.9%) |
| Jun 2018 | - | $668.00 K(-12.2%) |
| Mar 2018 | - | $761.10 K(-20.0%) |
| Dec 2017 | $951.80 K(-11.9%) | $951.80 K(-21.1%) |
| Sep 2017 | - | $1.21 M(+30.5%) |
| Jun 2017 | - | $924.70 K(-1.2%) |
| Mar 2017 | - | $935.60 K(-13.7%) |
| Dec 2016 | $1.08 M(-42.9%) | $1.08 M(-20.2%) |
| Sep 2016 | - | $1.36 M(-12.7%) |
| Jun 2016 | - | $1.56 M(-17.2%) |
| Mar 2016 | - | $1.88 M(-0.6%) |
| Dec 2015 | $1.89 M(-16.4%) | $1.89 M(-30.8%) |
| Sep 2015 | - | $2.73 M(-7.6%) |
| Jun 2015 | - | $2.96 M(+7.7%) |
| Mar 2015 | - | $2.75 M(+21.4%) |
| Dec 2014 | $2.26 M(-8.7%) | $2.26 M(-12.8%) |
| Sep 2014 | - | $2.59 M(-11.7%) |
| Jun 2014 | - | $2.94 M(+12.1%) |
| Mar 2014 | - | $2.62 M(+5.8%) |
| Dec 2013 | $2.48 M(+88.9%) | $2.48 M(+135.5%) |
| Sep 2013 | - | $1.05 M(-14.2%) |
| Jun 2013 | - | $1.23 M(-3.5%) |
| Mar 2013 | - | $1.27 M(-3.1%) |
| Dec 2012 | $1.31 M(-37.5%) | $1.31 M(+5.9%) |
| Sep 2012 | - | $1.24 M(+4.1%) |
| Jun 2012 | - | $1.19 M(-4.3%) |
| Mar 2012 | - | $1.24 M(-40.8%) |
| Dec 2011 | $2.10 M(+35.9%) | $2.10 M(+32.4%) |
| Sep 2011 | - | $1.59 M(-4.3%) |
| Jun 2011 | - | $1.66 M(-2.9%) |
| Mar 2011 | - | $1.71 M(+10.5%) |
| Dec 2010 | $1.54 M | $1.54 M(-19.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2010 | - | $1.91 M(+3.2%) |
| Jun 2010 | - | $1.85 M(-5.1%) |
| Mar 2010 | - | $1.95 M(+0.8%) |
| Dec 2009 | $1.92 M(+33.7%) | $1.93 M(+28.4%) |
| Sep 2009 | - | $1.51 M(+5.4%) |
| Jun 2009 | - | $1.43 M(+5.8%) |
| Mar 2009 | - | $1.35 M(-7.2%) |
| Dec 2008 | $1.44 M(-34.3%) | $1.45 M(-15.8%) |
| Sep 2008 | - | $1.73 M(-16.2%) |
| Jun 2008 | - | $2.06 M(-1.3%) |
| Mar 2008 | - | $2.09 M(-5.2%) |
| Dec 2007 | $2.19 M(+128.6%) | $2.20 M(+38.3%) |
| Sep 2007 | - | $1.59 M(+6.7%) |
| Jun 2007 | - | $1.49 M(+58.0%) |
| Mar 2007 | - | $944.80 K(-1.2%) |
| Dec 2006 | $956.10 K(-9.0%) | $956.60 K(-10.2%) |
| Sep 2006 | - | $1.07 M(-0.8%) |
| Jun 2006 | - | $1.07 M(+2.8%) |
| Mar 2006 | - | $1.04 M(-0.6%) |
| Dec 2005 | $1.05 M(+134.8%) | $1.05 M(+132.6%) |
| Sep 2005 | - | $452.10 K(+1.2%) |
| Jun 2005 | - | $446.80 K(-0.4%) |
| Mar 2005 | - | $448.40 K(+0.2%) |
| Dec 2004 | $447.70 K(+353.1%) | $447.50 K(+109.7%) |
| Sep 2004 | - | $213.40 K(+45.4%) |
| Jun 2004 | - | $146.80 K(-13.7%) |
| Mar 2004 | - | $170.20 K(+71.9%) |
| Dec 2003 | $98.80 K(-76.9%) | $99.00 K(-55.1%) |
| Sep 2003 | - | $220.60 K(-43.5%) |
| Jun 2003 | - | $390.30 K(-8.3%) |
| Mar 2003 | - | $425.50 K(-0.9%) |
| Dec 2002 | $428.30 K(-22.8%) | $429.40 K(+10.7%) |
| Sep 2002 | - | $388.00 K(-16.5%) |
| Jun 2002 | - | $464.70 K(+6.5%) |
| Mar 2002 | - | $436.50 K(-21.6%) |
| Dec 2001 | $555.10 K(+75.9%) | $556.90 K(-5.4%) |
| Sep 2001 | - | $588.90 K(-8.5%) |
| Jun 2001 | - | $643.60 K(+20.7%) |
| Mar 2001 | - | $533.30 K(+68.9%) |
| Dec 2000 | $315.50 K(+402.4%) | $315.70 K(+679.5%) |
| Sep 2000 | - | $40.50 K(-40.0%) |
| Jun 2000 | - | $67.50 K(-83.7%) |
| Mar 2000 | - | $413.10 K(+554.7%) |
| Dec 1999 | $62.80 K(-2.8%) | $63.10 K(-7.3%) |
| Sep 1999 | - | $68.10 K(+0.4%) |
| Jun 1999 | - | $67.80 K(+2.3%) |
| Mar 1999 | - | $66.30 K(+2.0%) |
| Dec 1998 | $64.60 K(-69.1%) | $65.00 K(-0.8%) |
| Sep 1998 | - | $65.50 K(-90.4%) |
| Jun 1998 | - | $680.70 K(-3.4%) |
| Mar 1998 | - | $704.50 K(+236.1%) |
| Dec 1997 | $209.30 K(-94.4%) | $209.60 K(-94.2%) |
| Sep 1997 | - | $3.62 M(-5.7%) |
| Jun 1997 | - | $3.84 M(-1.9%) |
| Mar 1997 | - | $3.91 M |
| Dec 1996 | $3.72 M | - |
FAQ
- What is COSCIENS Biopharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for COSCIENS Biopharma?
- What is COSCIENS Biopharma annual total long term liabilities year-on-year change?
- What is COSCIENS Biopharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly long term liabilities year-on-year change?
What is COSCIENS Biopharma annual total long term liabilities?
The current annual total long term liabilities of CSCI is $1.40 M
What is the all time high annual total long term liabilities for COSCIENS Biopharma?
COSCIENS Biopharma all-time high annual total long term liabilities is $3.72 M
What is COSCIENS Biopharma annual total long term liabilities year-on-year change?
Over the past year, CSCI annual total long term liabilities has changed by -$1.07 M (-43.34%)
What is COSCIENS Biopharma quarterly total long term liabilities?
The current quarterly long term liabilities of CSCI is $15.59 M
What is the all time high quarterly long term liabilities for COSCIENS Biopharma?
COSCIENS Biopharma all-time high quarterly total long term liabilities is $15.59 M
What is COSCIENS Biopharma quarterly long term liabilities year-on-year change?
Over the past year, CSCI quarterly total long term liabilities has changed by +$14.19 M (+1016.38%)